Foghorn Therapeutics, Inc. (FHTX)
6.00
-0.22
(-3.54%)
USD |
NASDAQ |
Aug 28, 16:00
6.00
0.00 (0.00%)
After-Hours: 18:38
Foghorn Therapeutics Total Liabilities (Quarterly) : 284.43M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 284.43M |
| March 31, 2026 | 298.58M |
| December 31, 2025 | 503.16M |
| September 30, 2025 | 294.62M |
| June 30, 2025 | 302.90M |
| March 31, 2025 | 320.34M |
| December 31, 2024 | 503.90M |
| September 30, 2024 | 336.66M |
| June 30, 2024 | 342.91M |
| March 31, 2024 | 352.49M |
| December 31, 2023 | 363.11M |
| September 30, 2023 | 370.81M |
| Date | Value |
|---|---|
| June 30, 2023 | 388.93M |
| March 31, 2023 | 397.47M |
| December 31, 2022 | 404.77M |
| September 30, 2022 | 409.61M |
| June 30, 2022 | 409.27M |
| March 31, 2022 | 415.90M |
| December 31, 2021 | 422.90M |
| September 30, 2021 | 105.09M |
| June 30, 2021 | 104.34M |
| March 31, 2021 | 104.72M |
| December 31, 2020 | 109.41M |
| September 30, 2020 | 275.75M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Prime Medicine, Inc. | 209.23M |
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 203.39M |
| Shareholders Equity (Quarterly) | -81.04M |
| Debt to Equity Ratio | -0.5319 |
| Current Ratio | 3.362 |
| Net Debt Paydown Yield | -0.58% |